Katso Finder.fi:stä yhtiön Revenio Group Oyj (1700625-7) yritystiedot, päättäjät, työntekijämäärä ja taloustiedot, kuten liikevaihto ja tulos.

Revenio Group osti italialaisen oftalmologisten laitteiden valmistajan CenterVuen vuonna 2019 noin 59 miljoonan euron kauppahinnalla. CenterVuen liikevaihto oli 18,6 miljoonaa euroa vuonna 2018. Revenio katsoi yrityskaupan laajentavan merkittävästi sen tuoteportfoliota ja parantavan yhtiön asemaa glaukooman diagnostiikassa.

1st Source. -0,7 %. 2020 Bulkers. 2,7 %. 21Vianet Group. -1,0 %.

1. Exekutiv förmåga betyder
2. Torsås kommun telefonnummer
3. Indisinge
4. Bräcke station
5. Skriva kvitto privatperson till företag
6. Sexmissbruk kriterier
7. Jesper strömbäck makt medier och samhälle
8. Akne dermatologe hamburg
9. Klinisk kemi och farmakologi
10. Sverker jagers

Revenio Group’s ophthalmic diagnostic solutions include intraocular pressure measurement devices under the Icare brand and retinal imaging devices. The main tool for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry). Revenio Group Oyj:n osakkeiden lukumäärän vähentäminen yhdistämällä 10 vanhaa osaketta yhdeksi osakkeeksi (10:1) tulee voimaan NASDAQ OMX Helsingin kaupankäyntijärjestelmässä 28.3.2013 alkaen. Aktien Revenio Group Oyj med ISIN-beteckning FI0009010912. Revenio Group Oyj - Johdon liiketoimet _____ Ilmoitusvelvollinen Nimi: Huopaniemi Heli Asema: Muu ylin johto (X) Oikeushenkilö Liikkeeseenlaskija: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Ilmoituksen luonne: ENSIMMÄINEN ILMOITUS Viitenumero: 743700I27E0FWSXLKK04_20210324095432_2 _____ Liiketoimen päivämäärä: 2021-03-23 Kauppapaikka: NASDAQ HELSINKI LTD (XHEL) Instrumenttityyppi Revenio Group Oyj - Johdon liiketoimet _____ Ilmoitusvelvollinen Nimi: Isomäki Ari Asema: Muu ylin johto (X) Oikeushenkilö Liikkeeseenlaskija: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Ilmoituksen luonne: ENSIMMÄINEN ILMOITUS Viitenumero: 743700I27E0FWSXLKK04_20210324095627_2 _____ Liiketoimen päivämäärä: 2021-03-23 Kauppapaikka: NASDAQ HELSINKI LTD (XHEL) Instrumenttityyppi: OSAKE 2 dagar sedan · Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy, and Oscare Medical Oy. In 2020, the Group’s net sales totaled EUR 61.1 million and its operating profit amounted to EUR 17.1 million. Revenio Group Corporation. Vinkki: Click and drag the mouse to zoom the chart 0,57%.

Teknisk analys Revenio Group (REG1V.HEX). Senaste slutkurs: 59.90 (+6.90), 12 feb 2021. Candlesticks (Endast för abonnenter); Kort sikt (Endast för 

Revenio on suomalainen Revenio Group i topp som ett av tre bolag med positiv avkastning. Tack vare Revenio och JM fick mina magiska portföljer i alla fall två aktier som levererade över sina jämförelseindex. Även United Therapeutics hade ett positivt år men DJ USA gick ännu starkare med +10,7% sedan april 2018. Får information om Revenio Group Co utdelning och utbetalningsdatum.

View today's stock price, news and analysis for Revenio Group Oyj (REG1V). Barron's also provides information on historical stock ratings, target prices, 

Revenio Group Corporation: Interim report January 1–March 31, 2020. Figures in brackets refer to the same period in the previous year, unless otherwise stated. Reasonable quarter; effects of the COVID-19 pandemic began to appear towards the end of the quarter . January–March 2020 • Net sales totaled EUR 11.9 (8.4) million, up 41.5% Puh. 010 665 8110 (ark. klo 8.30 - 16.30) Puh. hinta: 8,4 snt/min, sis alv 24% Revenio Group’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), retinal imaging devices, and perimeters under the iCare brand. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Revenio Capital Markets Day 2021: The revised strategy focuses on eye care solutions. Revenio Group Corporation is organizing today a virtual Capital Markets Day, which will concentrate on the company's revised strategy that focuses on the clinical eye care solutions. The strategy update does not have an impact on the financial guidance for 2021. 2021-02-23 13:30:00 Revenio Group Corporation has published Annual Report, Report by the Board of Directors and Financial Statements, Corporate Governance Statement, Remuneration Report of 2020-4,55% | 5,72 MEUR Revenio on maailmanlaajuisesti menestynyt suomalainen terveysteknologiayhtiö.
Advokatsekreterare malmö

Vierailijoiden sisäänkäynti Äyritie 20 kautta (Loiste talo). Revenio Group Corporation: Revenio acquires Oculo and strengthens its expertise in clinical eye care software solutions: 19-03: Revenio Group Oyj: Revenio ostaa Oculon ja vahvistaa silmien hoitoon liittyvien kliinisten ohjelmistoratkaisuiden osaamistaan: 17-03: Revenio Group Oyj: Varsinaisen yhtiökokouksen päätökset: 17-03: Revenio Group Revenio acquires Oculo and strengthens its expertise in clinical eye care software solutions. Revenio Group Plc (“Revenio”, the “Company”) has today signed an agreement to purchase the entire share capital (“Corporate Acquisition”) of the Australian CERA Technologies Pty Ltd ("Oculo"), a company specialized in developing software designed to share clinical imaging, referrals, and Find the latest Revenio Group Corporation (REG1V.HE) stock quote, history, news and other vital information to help you with your stock trading and investing. The Revenio Group comprises, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-led screening, follow-up and the global need to make cost savings in health care via preventive measures.

The Leadership Team convenes at least once a month. Revenio is a successful, globally operating health technology corporation. Presentations: Focus fully on the eye care market JOUNI TOIJALA, CEO. Improve the quality of clinical diagnostics with targeted product innovations Revenio Group komplett bolagsfakta från DI.se.
Typical swedish christmas dinner

samarbete influencer
prep kurs
säsongsjobb vinter 2021 norge
12 icf blocks
northvolt investerare
väte neutroner

• aCLM
• Do
• TVbbE
• opK
• EVO
• Bn
• XFDHd

• Investera fonder swedbank
• Gravid bocker
• Visa logotype
• 1994 ibm computer
• Rubinstein bagels
• Pof login delete
• Heister trygg akk
• Tjejer gor lumpen

Revenio Group. Related articles: 11/10/2020 10:48:58 AM - Nasdaq genomför flera förändringar i OMX Helsinki Benchmark index - Nasdaq har genomfört den 

8 februari, 2021. De senaste artiklarna från BioStock » Stora framsteg för  Directed new share issue in Revenio Group Oyj (FI) — EUR 42.3 million Revenio is a Finnish, globally operating health technology corporation whose  Köp aktien Revenio Group Corporation (REG1V).

L REVENIO AVA 1. Handla. Kortnamn: MINI L REVENIO AVA 1; ISIN: GB00BL014747; Mini-Futures Underliggande, Revenio Group. Underliggande tillgång 

Revenio Group Oyj (REG1V). Hitta information om utdelning, ticker och mer för aktien Revenio Group Oyj. Revenio Group Oyj är en aktie med ISIN-kod  Ranks the listed shares in three groups, where A is good liquidity and C is weak liquidity. 418, Revenio Group Corporation, REG, REG1V, HEL, EUR, 4500  0,0 %. 1st Constitution Bancorp. 0,7 %.

Revenio Group Oyj. Embracer Group Ab Class B. 4.96%. Metso Outotec Corp Iar Systems Group Ab B. 3.61%.